GEODE CAPITAL MANAGEMENT, LLC - ACURX PHARMACEUTICALS INC ownership

ACURX PHARMACEUTICALS INC's ticker is ACXP and the CUSIP is 00510M104. A total of 15 filers reported holding ACURX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ACURX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$126,716
-38.1%
88,595
+14.6%
0.00%
Q2 2023$204,799
-23.4%
77,2830.0%0.00%
Q1 2023$267,399
+87000.7%
77,2830.0%0.00%
Q4 2022$307
-99.9%
77,283
+1.4%
0.00%
Q3 2022$228,000
+430.2%
76,241
+561.0%
0.00%
Q2 2022$43,000
+22.9%
11,535
+5.4%
0.00%
Q1 2022$35,00010,9410.00%
Other shareholders
ACURX PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Patriot Financial Group Insurance Agency, LLC 7,000$30,0000.01%
Semmax Financial Advisors Inc. 1,263$5,0000.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 25,100$108,0000.00%
TD Waterhouse Canada Inc. 30,000$138,3000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 13,949$61,0000.00%
MORGAN STANLEY 3$00.00%
BlackRock Inc. 6,685$29,0000.00%
HRT FINANCIAL LP 14,369$62,0000.00%
OSAIC HOLDINGS, INC. 5,000$22,0000.00%
View complete list of ACURX PHARMACEUTICALS INC shareholders